Vigil Neuroscience, Inc.
Records under this name other than the patents Vigil Neuroscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 3 of 3 · Back to Vigil Neuroscience, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,718,617 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid CELLS2 Agonists and Methods of Use Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,252,489 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 12,319,691 | Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use Formerly held In force · Medium confidence | In force | Medium confidence |